We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Defines ‘Counterfeit’ Devices in Draft Guidance
FDA Defines ‘Counterfeit’ Devices in Draft Guidance
The FDA has issued a draft guidance explaining how it defines and distinguishes “counterfeit” devices from the genuine article, as part of its implementation of the Safeguarding Therapeutics Act enacted Jan. 5.